Solving the Hardest Problems in Cell and Gene Therapy Manufacturing

Enabling next-generation cell & gene therapies through non-viral cell engineering

Designed to tackle the toughest challenges in cell & gene therapy

A focused non-viral gene delivery platform designed for scalable, stress-controlled cell engineering

From gene delivery to GMP-ready, scalable manufacturing

FDA Drug Master File (DMF) registered platform with continuous-flow, temperature-controlled electroporation

What is CellShot Platform?

CellShot PFEP™

Physicochemical μ-environments

CellShot PROLIVA™

Biochemical Architecture

A new class of non-viral gene delivery platform—designed for living cell manufacturing

CellShot® is not just an electroporation device. It is a system-level platform that redefines how electric fields, buffers, and cells interact — enabling non-destructive, scalable gene delivery from transfection to cryopreservation. These functionally separated microenvironments are further optimized by CellShot Proliva™ buffer architecture, enabling precise stress control throughout the transfection process.

Manufacturing-Grade Non-Viral Gene Transfer

Platform

Device

FEMTOBIOMED Cellshot® Controller
Automated and precisely regulated electroporation control systemAutomated and regulated control system

Consumables

FEMTOBIOMED Cellshot® TX Cartridge
Single-use GMP-ready cartridges ensuring sterility

SW & DB

Remote System
Management

CellShot Proliva™ Buffer Technology

Beyond a Single Buffer
A Phase-Specific Buffer Architecture for Non-Destructive Gene Delivery

CellShot Proliva™ is not a single formulation, but a buffer architecture engineered to manage cellular stress before, during, and after non-viral gene delivery.

By functionally separating electrical conduction, cellular exposure, and post-transfection recovery, Proliva™ preserves cell health across the entire manufacturing workflow.

Field Optimized Buffering

Cell-Centric Transfection Buffering

Rapid Recovery & Expansion Support

Stress Trajectory Control

Manufacturing-Ready by Design

One Platform, Multiple Payloads
Optimized for CMC Consistency

A unified CPP architecture for manufacturable multigenic delivery

CellShot provides a unified CPP architecture that enables diverse genetic payloads to be delivered under consistent, manufacturing-optimized conditions—reducing CMC complexity while preserving cell health and product quality.